The Bartter Syndrome Gene Panel by NGS is a specialized molecular test designed to identify genetic mutations responsible for Bartter Syndrome, a rare inherited kidney disorder affecting electrolyte balance. Metropolis Healthcare uses advanced next-generation sequencing to analyze multiple genes involved in renal salt-wasting and related metabolic abnormalities. This test helps confirm diagnosis, guide treatment decisions, and support genetic counseling. It is especially useful when clinical signs point toward a hereditary tubular disorder.
Price:
Rs. 21,000.00
Sample Type: EDTA BLOOD
Fasting Not Required
Notes:G0169
Frequently Asked Questions (FAQ's):
What does this test include at Metropolis Healthcare?
It includes next-generation sequencing of genes known to cause Bartter Syndrome and related renal tubular disorders.
How does Metropolis Healthcare perform this test?
DNA is extracted from an EDTA blood sample and analyzed using high-precision NGS platforms to detect pathogenic variants.
Who should take this test at Metropolis Healthcare?
Individuals with symptoms such as recurrent dehydration, failure to thrive, metabolic alkalosis, low potassium, or suspected inherited kidney disease.
What sample is required at Metropolis Healthcare?
A standard EDTA blood sample is required for DNA extraction and sequencing.
How does this test help clinicians at Metropolis Healthcare?
It confirms the genetic basis of Bartter Syndrome, helps determine subtype, and guides long-term management and family counseling.
Is any preparation needed before giving the sample at Metropolis Healthcare?
No fasting or special preparation is needed for this test.
How long does the test take at Metropolis Healthcare?
Turnaround time generally ranges from several days to a few weeks due to detailed genetic analysis.
When will I receive the report from Metropolis Healthcare?
Reports are issued as per the molecular diagnostics schedule, accompanied by expert genetic interpretation.